The Board of Directors of the Canadian Partnership Against Cancer is pleased to announce the appointment of Dr. Craig Earle as CEO effective November 1, 2021.
“Since 2017, Dr. Earle has made stellar contributions as part of the Partnership’s executive team and contributing as practicing oncologist, scientist, cancer researcher and academic. It is this wealth of experience and expertise that, together with his four years of leadership as VP of the Cancer Control Division, made Craig the optimal candidate to be the Partnership’s next CEO,” said Dr. Graham Sher, Chair of the Partnership’s Board of Directors.
The Partnership has the privilege of a stable, long-term vision in the refreshed Canadian Strategy for Cancer Control that will guide the work ahead across Canada and for the organization. “It is an exciting time in the implementation of the Strategy as the Partnership, the steward of the Strategy, explores how to work with existing partners and reach new partners in its journey to achieve equitable cancer care for all people living in Canada,” commented Ms. Morton, “I’m thrilled at the Board’s choice of Craig, as he has earned his place in Canada’s cancer control leadership, both as our VP and his long, impressive career in the cancer system.”
We have a remarkable organization with outstanding partners all working towards the same goal of improving equitable access to quality cancer care across Canada.
I’m excited to keep pushing this work forward, assist the country’s cancer system with pandemic recovery, and to face whatever new opportunities and challenges come our way.
-Dr. Craig Earle
To the role of CEO, Dr. Earle brings strong executive and healthcare leadership skills. In addition to his new role as CEO of the Canadian Partnership Against Cancer, Dr. Earle is a Medical Oncologist at Sunnybrook’s Odette Cancer Centre in Toronto, a Senior Scientist at ICES, and a Professor of Medicine at the University of Toronto.
Please join us in welcoming Dr. Earle as the Partnership’s next CEO.